- Home
- ENLV vs TRT Comparison
ENLV vs TRT Comparison
Compare ENLV & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- TRT
- Stock Information
- Founded
- ENLV 2005
- TRT 1958
- Country
- ENLV Israel
- TRT United States
- Employees
- ENLV N/A
- TRT N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- ENLV Health Care
- TRT Technology
- Exchange
- ENLV Nasdaq
- TRT Nasdaq
- Market Cap
- ENLV 31.5M
- TRT 30.5M
- IPO Year
- ENLV 1995
- TRT N/A
- Fundamental
- Price
- ENLV $1.09
- TRT $6.90
- Analyst Decision
- ENLV Strong Buy
- TRT
- Analyst Count
- ENLV 2
- TRT 0
- Target Price
- ENLV $9.50
- TRT N/A
- AVG Volume (30 Days)
- ENLV 173.7K
- TRT 10.8K
- Earning Date
- ENLV 11-30-2024
- TRT 11-12-2024
- Dividend Yield
- ENLV N/A
- TRT N/A
- EPS Growth
- ENLV N/A
- TRT N/A
- EPS
- ENLV N/A
- TRT 0.13
- Revenue
- ENLV N/A
- TRT $42,145,000.00
- Revenue This Year
- ENLV N/A
- TRT N/A
- Revenue Next Year
- ENLV N/A
- TRT N/A
- P/E Ratio
- ENLV N/A
- TRT $52.34
- Revenue Growth
- ENLV N/A
- TRT 2.10
- 52 Week Low
- ENLV $1.08
- TRT $4.64
- 52 Week High
- ENLV $4.59
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- ENLV 27.79
- TRT 53.67
- Support Level
- ENLV $1.13
- TRT $6.47
- Resistance Level
- ENLV $1.33
- TRT $7.29
- Average True Range (ATR)
- ENLV 0.10
- TRT 0.40
- MACD
- ENLV -0.02
- TRT -0.00
- Stochastic Oscillator
- ENLV 6.52
- TRT 63.89
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.